Drug search by name
Canakinumab Subcutaneous and Incruse Ellipta
Determining the interaction of Canakinumab Subcutaneous and Incruse Ellipta and the possibility of their joint administration.
Check result:
Canakinumab Subcutaneous <> Incruse Ellipta
Relevance: 24.10.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Canakinumab Subcutaneous
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Incruse Ellipta
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Canakinumab Subcutaneous-Indacaterol
- Canakinumab Subcutaneous-Indacaterol and Glycopyrrolate
- Canakinumab Subcutaneous-Indacaterol and glycopyrrolate Inhalation
- Canakinumab Subcutaneous-Indacaterol inhalation
- Canakinumab Subcutaneous-Indacaterol Maleate
- Canakinumab Subcutaneous-Indapamide
- Incruse Ellipta-Canasa
- Incruse Ellipta-Canasa Pac rectal
- Incruse Ellipta-Canasa rectal
- Incruse Ellipta-Cancidas
- Incruse Ellipta-Candesartan
- Incruse Ellipta-Candesartan and Hydrochlorothiazide
Doktika World
Interaction with food and lifestyle
Disease interaction